|
UR8000 Coagulation Analyzer – High-Throughput Automated Hemostasis Testing System
As hospital labs face rising test volumes and tighter turnaround times, automated coagulation analyzers have become critical infrastructure. The UR8000 reflects China’s capacity to deliver high-throughput diagnostic hardware that competes on both speed and operational intelligence.
Central laboratories processing hundreds of coagulation samples daily face a persistent bottleneck: throughput without compromising assay accuracy. The UR8000, from Shenzhen-based Sunbiote, is a response to that pressure. With a rated output of 900 tests per hour and 40 parallel detection channels, it is designed for environments where PT, APTT, FIB, and D-Dimer results must flow continuously.
The system consolidates coagulation, immunoturbidimetric, and chromogenic assays into a single platform—reducing the need for separate workstations. This is not merely a convenience; it reflects a broader shift in lab procurement toward multi-parameter instruments that optimise both floor space and reagent logistics.
Operationally, the UR8000 removes friction through intelligent sample pre-screening: automatic detection of hemolysis, icterus, and lipemia curbs the need for manual re-runs. Closed-tube sampling and cap-piercing reduce biohazard exposure, a design priority that aligns with stricter biosafety standards emerging across Chinese hospital networks.
The instrument’s compatibility with laboratory automation systems signals that it is built for the integrated lab. In practice, this means the UR8000 can plug into track-based sample transport and middleware orchestration, allowing labs to scale without disruptive workflow redesign.
For domestic manufacturers, the UR8000 demonstrates that high-speed hemostasis analyzers are no longer the preserve of a few global incumbents. China’s in vitro diagnostics supply chain now produces systems capable of sustaining the throughput demands of a tier-1 hospital lab.
The real test will be long-term reliability under load. But the UR8000’s specifications suggest a product built with the operational realities of busy clinical labs in mind—not just feature lists, but genuine workflow integration.
For labs evaluating automation upgrades, the question is no longer whether domestic alternatives exist, but how quickly they can be validated and integrated into existing systems.
Why it matters:
The UR8000 gives lab directors a high-throughput coagulation option that competes on speed and assay flexibility. For procurement teams, it represents a domestically produced alternative that reduces reliance on imported analyzers without compromising on automation or biosafety features.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.